The results of this study showed a significant correlation between this profibrotic macrophage subset (CD9+TREM2+ macrophages) and the severity of liver fibrosis in patients with NAFLD. The gene discussed is CD9; the disease is metabolic dysfunction-associated steatotic liver disease.